Homotypic interactions of the infectious bursal disease virus proteins VP3, pVP2, VP4, and VP5: mapping of the interacting domains  by Tacken, Mirriam G.J et al.
Homotypic interactions of the infectious bursal disease virus proteins
VP3, pVP2, VP4, and VP5: mapping of the interacting domains
Mirriam G.J. Tacken,a,* Patricia A.J. Van Den Beuken,a Ben P.H. Peeters,a
Adri A.M. Thomas,b Peter J.M. Rottier,c and Hein J. Boota
a Institute for Animal Science and Health (ID-Lelystad B.V.), Division of Infectious Diseases and Food Chain Quality, P.O. Box 65,
NL-8200 AB Lelystad, The Netherlands
b Utrecht University, Department of Developmental Biology, Utrecht, The Netherlands
c Utrecht University, Veterinary Faculty, Virology Division, Utrecht, The Netherlands
Received 9 September 2002; returned to author for revision 6 January 2003; accepted 18 February 2003
Abstract
Infectious bursal disease virus (IBDV), a nonenveloped double-stranded RNA virus of chicken, encodes five proteins. Of these, the
RNA-dependent RNA polymerase (VP1) is specified by the smaller genome segment, while the large segment directs synthesis of a
nonstructural protein (VP5) and a structural protein precursor from which the capsid proteins pVP2 and VP3 as well as the viral protease
VP4 are derived. Using the recently redefined processing sites of the precursor, we have reevaluated the homotypic interactions of the viral
proteins using the yeast two-hybrid system. Except for VP1, which interacted weakly, all proteins appeared to self-associate strongly. Using
a deletion mutagenesis approach, we subsequently mapped the interacting domains in these polypeptides, where possible confirming the
observations made in the two-hybrid system by performing coimmunoprecipitation analyses of tagged protein constructs coexpressed in
avian culture cells. The results revealed that pVP2 possesses multiple interaction domains, consistent with available structural information
about this external capsid protein. VP3–VP3 interactions were mapped to the amino-terminal part of the polypeptide. Interestingly, this
domain is distinct from two other interaction domains occurring in this internal capsid protein: while binding to VP1 has been mapped to
the carboxy-terminal end of the protein, interaction with the genomic dsRNA segments has been suggested to occur just upstream thereof.
No interaction sites could be assigned to the VP4 protein; any deletion applied abolished its self-association. Finally, one interaction domain
was detected in the central, most hydrophobic region of VP5, supporting the idea that this virulence determinant may function as a
membrane pore-forming protein in infected cells.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Infectious bursal disease (IBD), also known as Gumboro
disease, is an acute contagious viral disease of young chick-
ens that is of major importance for the poultry industry
(Cheville, 1967). The IBD virus (IBDV) causes a severe
immunosuppression by destroying B-lymphoid cells present
in the bursa of Fabricius followed by bursal atrophy. The
immunosuppression leads to an increased susceptibility to
other pathogens and reduces the growth rate of surviving
animals (Kibenge et al., 1988). To date, two distinct sero-
types (I and II) of IBDV have been identified (Jackwood et
al., 1982). The pathogenic serotype I viruses are isolated
from chickens and vary in virulence. Serotype II viruses are
nonpathogenic and occur in turkeys and chickens (Jack-
wood et al., 1982; McFerran et al., 1980).
IBDV belongs to the family Birnaviridae (Leong et al.,
2000). Members of the family contain a double-stranded
RNA (dsRNA) genome consisting of two segments, desig-
nated A and B, within an unenveloped single-shelled ico-
sahedral capsid of 60 nm in diameter (Dobos et al., 1979;
Muller et al., 1979). The smaller segment B (approximately
2.9 kb) encodes viral protein 1 (VP1; 95 kDa), the putative
RNA-dependent RNA polymerase (RdRp) (Bruenn, 1991;
Macreadie and Azad, 1993; Spies et al., 1987). This
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polypeptide is present in the virion both as a free protein and
as a genome-linked protein, called VPg, attached to the 5
end of the positive strands of the two genomic segments
(Dobos, 1993; Spies and Muller, 1990). Segment A (ap-
proximately 3.3 kb) contains two partially overlapping open
reading frames (ORFs). The first, smaller ORF encodes
nonstructural protein VP5, which is not essential for viral
replication in vitro but important for virus-induced patho-
genicity (Mundt et al., 1997; Yao et al., 1998). The larger
ORF encodes a 110-kDa polyprotein that is autocatalyti-
cally cleaved, rendering three polypeptides: pVP2 (48 kDa),
VP3 (32 kDa), and VP4 (28 kDa). VP4, a serine-lysine
protease (Birghan et al., 2000), is responsible for this self-
processing (Lejal et al., 2000; Sanchez and Rodriguez,
1999). It is a nonstructural protein mainly associated with
type II tubules of 24 nm in diameter (Granzow et al., 1997).
pVP2 is further processed at its carboxy-terminus to become
VP2 (40 kDa) (Da Costa et al., 2002; Lejal et al., 2000).
VP2 and VP3 are the structural proteins forming the outer
and inner layers of the virion, respectively (Bottcher et al.,
1997; Caston et al., 2001). Recently we showed that VP3
interacts not only with VP1 but also with the genomic
dsRNA segments A and B, the former interaction being of
crucial importance for IBDV replication (Tacken et al.,
2002).
Interactions among viral proteins and between viral and
host proteins play a central role in the infection process.
These interactions include transient as well as long-lived
associations. Often, these interactions establish essential
functional complexes responsible for processes such as viral
genome replication, RNA transcription and translation, vi-
rus assembly, and virus release. Identification of such pro-
tein–protein interactions is therefore of vital importance for
a better understanding of the dynamics of viral multiplica-
tion.
We have recently used the yeast two-hybrid system in
various interaction studies of the IBDV proteins. Thus, we
detected a number of candidate cellular interaction partners
for the IBDV proteins VP1, pVP2, VP3, and VP5 (Tacken
et al., 2001). One of these was further explored revealing an
interaction between VP1 and translational eukaryotic initi-
ation factor 4AII (eIF4AII) (M.G.J. Tacken, A.A.M.
Thomas, B.P.H. Peeters, P.J.M. Rottier, and H.J. Boot,
submitted for publication). We also used this system to
analyze the intermolecular interactions between the IBDV
proteins themselves (Tacken et al., 2000). Though the yeast
assays did not allow us to detect an interaction between the
two capsid proteins pVP2 and VP3, an interaction between
the latter and VP1, presumed to draw the polymerase into
assembling viral particles, was clearly demonstrated.
Whereas these studies also revealed homotypic interactions
of the IBDV structural proteins, the recent redefinition of
the processing scheme of the structural protein precursor
(Lejal et al., 2000; Sanchez and Rodriguez, 1999) now casts
some doubt on these observations. In the present study we
have first reevaluated our earlier findings based on the
newly established processing sites. This confirmed the ho-
motypic interactions found for pVP2, VP3, VP4, and VP5,
which we now also demonstrated by coimmunoprecipitation
of coexpressed tagged and untagged forms of the proteins.
We subsequently carried out deletion studies to map the
self-interacting domains in each of these proteins. It appears
that the different proteins interact through different domains
which for the VP3 protein identified yet another domain in
addition to the ones shown recently to be involved in asso-
ciating with VP1 and with genomic dsRNA of both segment
A and B.
Results
Interactions of pVP2, VP3, pVP4, VP1, and VP5 with
themselves and each other assayed in the yeast two-
hybrid system
The ability of the full-length viral proteins, VP1, pVP2,
VP3, VP4, and VP5, to interact with themselves or with
each other was reevaluated using the polypeptides pVP2,
VP3, and VP4 based on the corrected polyprotein cleavage
sites (compare Fig. 1C with 1D). cDNA fragments of IBDV
strain CEF94 encoding these polypeptides were generated
by PCR and subcloned into the plasmids pLexABD and
pB42AD for two-hybrid analysis. The plasmid pLexABD
constitutively expresses proteins as carboxy-terminal fu-
sions to a 202 amino acids sequence of the bacterial lexA
DNA-binding domain (BD). The plasmid pB42AD was used
as the expression vector for all transcriptional activation
domain (AD) fusion proteins. This plasmid expresses pro-
teins under the control of the galactose-inducible GAL1
promoter as carboxy-terminal fusions to a simian virus
SV40 (SV40) nuclear localization sequence, an influenza
virus hemagglutinin epitope tag, and the B42 AD. Protein
expression of the fusion plasmids was verified by Western
blot analysis (data not shown).
Plasmids pLexABD and pB42AD expressing VP1, pVP2,
VP3, VP4, and VP5 fusion proteins were cotransformed in
all possible pairwise combinations into the yeast strain Sac-
charomyces cerevisae EGY48[p8opLacZ]. This strain has
the upstream activating sequences of the chromosomal
LEU2 gene replaced with six LexA operators and contains
the p8op-LacZ reporter plasmid encoding the LacZ gene
under the control of eight LexA operators. Potential inter-
actions were then scored by testing for growth in synthetic
complete medium lacking leucine and for production of
-galactosidase (-gal) as observed by the appearance of
blue colonies on X-Gal-containing medium. The strength of
the protein–protein interaction was judged by the intensity
of the blue phenotype or by the time required for growth on
medium lacking leucine. At least seven independent trans-
formants of each strain were screened. Additionally, all
fusions were tested for intrinsic or nonspecific activation.
The pB42AD fusion plasmids were cotransformed with
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LexA fused to the human Lamin C protein to test for
specificity of interaction with each of the BD fusions, while
all the pLexABD fusion plasmids were cotransformed with
an empty AD to test for intrinsic activation. None of the
fusions did intrinsically or nonspecifically activate expres-
sion of the LEU2 and LacZ reporters, confirming the spec-
ificity of the test system for IBDV proteins. Plasmids con-
taining sequences encoding p53 fused to LexA and plasmids
with sequences of SV40 large T antigen fused to B42 were
cotransformed into EGY48[p8oplacZ] and used as a posi-
tive control. Strains containing these fusion proteins showed
visible growth in Leu medium after 2 days, and deep blue
colonies on X-Gal containing medium after 1 day. We
observed strong homologous interactions for the viral pro-
teins pVP2, VP3, VP4, and VP5, a possible though weak
homologous interaction for VP1 and one heterologous in-
teraction between VP1 and VP3 (Tables 2 and 3).
When we compare these results with those obtained
previously (Tacken et al., 2000), there is one apparent dif-
ference. The homologous interaction of VP4, which we
clearly observe in our present study, was not detected in our
earlier work. Apparently, the amino-terminal extension
abolished the protein’s ability to interact with itself.
Deletion mapping of the self-interacting domains of the
IBDV proteins using the yeast two-hybrid system
To study the domains involved in the homotypic inter-
actions of the pVP2, VP3, VP4, and VP5 proteins, five
different deletion mutants were initially generated for each
protein (Figs. 2A–D, nos. 2–6; dark gray depicted polypep-
tides). To simplify interpretation of the results, we divided
each of the viral proteins into four regions, designated
REGION I to IV, as shown in Fig. 2. All the deletion
mutants were expressed by both the pLexABD and the
pB42AD expression vectors and the fusion products were
tested for their capability to interact with their respective
full-length protein. To rule out the possibility of nonspecific
transactivation of the reporter genes, all constructs were
additionally assayed for reporter gene activation when ex-
pressed either alone or together with the control plasmids
Fig. 1. Comparison of the previously and currently used two-hybrid fusion proteins encoding the viral proteins pVP2, VP4, and VP3 of IBDV. (A and B)
Schematic representation of the IBDV polyprotein; the pVP2–VP4 and VP4–VP3 junctions of the polyprotein are indicated based (A) on the putative
cleavage sites reported by Hudson et al., (1986) and (B) based on the recently corrected cleavage sites (Lejal et al., 2000; Sanchez and Rodriguez, 1999).
(C and D) Schematic representation of the polypeptides used for the two-hybrid analysis; (C) previously used (Tacken et al., 2000) and (D) currently used.
The first and last amino acid as well as the position of expressed regions are indicated.
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Fig. 2. Deletion mapping of the regions in pVP2, VP3, VP4, and VP5 responsible for homologous interaction by using the yeast two-hybrid system. All of the
deletion mutants were cloned into pLexABD and pB42AD yeast expression vectors and tested for their ability to interact with full-length pVP2 (A), VP3 (B), VP4
(C), or VP5 (D). Left: Overview of the deletion mutants that were assayed. The graded line above each panel denotes the amino acid (AA) positions of the primary
full-length sequence of each viral protein. A breakdown of the polypeptides into REGIONS I–IV is shown by shaded areas. Polypeptides depicted dark gray were
used for an initial mapping; polypeptides depicted light gray were assayed subsequently for fine mapping. The polypeptides denoted in boldface type were
additionally assayed for interaction with their full-length cognate protein in vivo by coimmunoprecipitation analysis (see text). Right: Interaction data obtained with
double transformants. Interactions were assayed for leucine autotrophy (Leu) and for -galactosidase activity (LacZ). Leu: , clear growth after 1 day (very
strong interaction); , clear growth after 2 days (strong interaction); , growth (interaction); /, limited growth (weak interaction); , no growth (no
interaction). LacZ: , deep blue colonies (very strong interaction); , blue colonies (strong interaction); , light blue colonies (interaction); /, very light
blue (weak interaction); , white colonies (no interaction). All results shown are representative of at least seven independent transformants.
pLexABD-Lamin C or pB42AD-empty. All constructs
proved to be negative in these tests (data not shown).
The results of the assays are presented in Fig. 2. Of the
pVP2 deletion mutants all truncated fusion proteins scored
positive in the -gal and Leu growth tests, albeit with
some variation in interaction strength (Fig. 2A, nos. 2–6).
The observation that both the amino-terminal and the car-
boxy-terminal half of the pVP2 protein were able by them-
selves to interact with the full-size polypeptide suggests that
the homotypic interactions between pVP2 molecules are
based on more than one contact site. For VP3 the critical
domains for interaction are located in the amino-terminal
part. Carboxy-terminal deletion of one-fourth or one-half of
the protein as in VP3C64 and VP3C129 was without
measurable effect on the strength of the interaction with
full-length VP3 (Fig. 2B, nos. 2–3). Truncations, however,
by 64 and 129 amino acids at the amino-terminus were
detrimental for their interaction with full-length VP3: the
scores with these polypeptides were (very) weak or even
negative (Fig. 2B, nos. 4–6). VP4–VP4 interaction ap-
peared to be extremely sensitive to modifications. Any de-
letion that we applied appeared to be invariably lethal (Fig.
2C, nos. 2–6). VP5–VP5 association on the other hand was
quite tolerant to deletions. All truncations except for the
construct VP5C73 (Fig. 2D, no. 3), which lacks the se-
quence for the carboxy-terminal half of the protein, scored
positive in both the -gal and the Leu growth test (Fig. 2D,
nos. 2–6). These results suggest that REGION III is respon-
sible for VP5 homomeric interaction.
Fine mapping the self-interaction sites of VP3 and VP5
using the yeast two-hybrid system
To determine the putative self-interacting domain of VP3
and VP5 more precisely, we constructed and tested four
additional progressive deletion mutants for each protein.
For VP3 a series of constructs was generated encoding
internal core protein fragments (Fig. 2B, nos. 7–9) as well as
an amino-terminal protein fragment (Fig. 2B, no. 10), each
comprising a part of REGION I and/or II. When these
constructs were assayed in the yeast two-hybrid system,
homotypic interactions were observed for all these polypep-
tides, though for three of them the interaction strength
measured in the pairing of pLexABD-VP3 (deletion mutant)
with pB42AD-VP3 (full-length) was significantly lower than
that in the reciprocal pairing of pB42AD-VP3 (deletion mu-
tant) with pLexABD-VP3 (full-length) (Fig. 2B, nos. 7, 9,
and 10). Such polarity of two-hybrid interactions has fre-
quently been observed (Cuconati et al., 1998; Xiang et al.,
1995) and is most likely an inherent consequence of the
two-hybrid assay. The fused LexABD- or B42AD-domain
might partly occlude the site of interaction, or the fusion
proteins may be folded improperly, unstable, or poorly
expressed. The VP3 mutant termed VP3N32/C129, how-
ever, interacted in both its polarities with the full-length
VP3 (Fig. 2B, no. 8) as strongly as full-length VP3 inter-
acted with itself (Fig. 2B, no. 1). Based on these results we
conclude the internal core protein fragment encompassing
residues 33 to 129 (i.e., REGION II and half of REGION I)
to be essential for VP3 homomeric interaction (Fig. 2B,
region between dotted lines).
The constructs that were generated for the further map-
ping of the interaction site in VP5 consisted of either the
complete REGION III (Fig. 2D, no. 7) or half of it, extended
on one side with REGION IV, REGION II, or REGION I
II (Fig. 2D, nos. 8–10). When the combined results of the
assays are considered, it is clear that the REGION III
amino-terminal half (residues 73–90; Fig. 2D, region be-
tween dotted lines) is essential for homotypic VP5 associ-
ation, with flanking domains additionally contributing to the
interaction. This is seen most convincingly by looking at the
effect of extending the nonfunctional amino-terminal half of
VP5 (REGION I  II; VP5C73; Fig. 2D, no. 3) with the
residue 73–90 fragment (VP5C55; no. 9), which renders
the polypeptide strongly association-competent. Extending
this construct further with the remaining part of REGION
III (no. 2) does not increase the interaction strength any
further. Conversely, the mere addition of the residue 73–90
fragment to the virtually inactive carboxy-terminal 55-res-
idue polypeptide VP5N90 (no. 8) generates a highly in-
teractive polypeptide VP5N72 (no. 5) to which further
amino-terminal extension (VP5N36; no. 4) does not seem
to add much. Though we did not test the residue 73–90
fragment independently, it is clear that the strength of its
interaction with full-size VP5 would not be very high and
that it requires the flanking regions as illustrated by the
extended polypeptides VP5N72/C37 (no. 7) and
VP5N36/C55 (no. 10), each of which binds with moderate
strength.
Homologous interactions of the full-length IBDV proteins
pVP2, VP3, and VP4 assayed by coimmunoprecipitation
analysis
To obtain corroborating evidence for the interactions
detected by the two-hybrid analyses, we employed a radio-
immunoprecipitation (RIP) assay using a cotransfection sys-
tem in which the respective proteins are transiently coex-
pressed in QM5 cells. To this end, we used plasmid
pHB36W, in which the full-length genomic cDNA of seg-
ment A of IBDV is cloned in a transcription plasmid be-
tween a T7 RNA polymerase promoter and the autocatalytic
hepatitis delta virus ribozyme sequence (Boot et al., 1999).
Furthermore, for the coexpression of the viral proteins we
used the transcription plasmid pGBKT7, in which the
cDNA of each of the viral proteins, pVP2, VP3, VP4, and
VP5, was cloned behind a T7 RNA polymerase promoter
sequence, in fusion with a sequence encoding the c-Myc
epitope tag. By using these tagged fusion proteins and
anti-c-Myc antibodies, it was possible to specifically precip-
itate only one of the two homologous interacting proteins
and to distinguish these proteins by a difference in their
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electrophoretic mobility (i.e., comparing the tagged and the
untagged protein) when analyzing the (co-)precipitates by
SDS–PAGE. The molecular size of the fused c-Myc tag,
including a small linker-peptide, is approximately 12 kDa.
The plasmids encoding the c-Myc-tagged proteins were
cotransfected with plasmid pHB36W into QM5 cells that
had previously been infected with a recombinant fowlpox
virus that expresses T7 RNA polymerase (Britton et al.,
1996). Forty-eight hours posttransfection, cells were meta-
bolically labeled for 3 h with [35S]methionine and subse-
quently subjected to immunoprecipitation with anti-c-Myc
serum. The immunoprecipitates obtained were analyzed by
SDS–PAGE and the labeled proteins were visualized by
autoradiography. Mock-transfected cells and cells trans-
fected with either pHB36W or the c-Myc-encoding plasmids
alone were used as controls for each immunoprecipitation.
As is clear from the results shown in Fig. 3, the c-Myc
antibody precipitated only the c-Myc-tagged fusion pro-
teins, indicating that it had no cross-reactivity (lanes 5–10).
Furthermore, in the immunoprecipitations of the cell lysates
of the cotransfected cells, the full-length untagged viral
proteins pVP2, VP3, and VP4 were each clearly coprecipi-
tated with their cognate c-Myc-tagged fusion protein (lanes
1–3). However, untagged full-length VP5 failed to be co-
precipitated with c-Myc-tagged VP5 (lane 4). The observa-
tion that the relative amounts of tagged pVP2 and VP3
versus untagged pVP2 and VP3 are substantially different,
whereas tagged and untagged VP4 showing nearly equiva-
lent amounts may be a consequence of different transfection
efficiencies. It is also possible that the tagged pVP2 and
VP3 proteins additionally interacted with themselves,
whereas tagged VP4 did not, or to a lesser extent.
Fine mapping of homotypic interactions of VP3 and VP5
by coimmunoprecipitation analysis
Using this in vivo coimmunoprecipitation assay, we ad-
ditionally analyzed several VP3 and VP5 truncation mutants
assayed earlier in the two-hybrid system (Fig. 2B, nos. 3, 5,
6, and 8–10; Fig. 2D, nos. 3 and 5–8; polypeptides denoted
in bold-faced type) for their ability to be coprecipitated with
their full-length cognate protein. For this purpose, the
pGBKT7 plasmids coding for the c-Myc-tagged VP3 or
VP5 full-length protein were coexpressed with a plasmid,
pGADT7, encoding a VP3- or VP5-deletion mutant protein
in fusion with an influenza virus hemagglutinin (HA)
epitope tag. By using two different tags, we were able to
assay for protein–protein interaction with two different an-
tibodies, specifically precipitating either the c-Myc-tagged
full-length protein or the HA-tagged deletion mutant. Fur-
thermore, by swapping the c-Myc and HA-fusions, the assay
was additionally performed reciprocally, namely by coex-
pressing HA-tagged full-length VP3 or VP5 together with
c-Myc-tagged VP3 or VP5 deletion mutant proteins.
Control experiments performed for each immunoprecipi-
tation using radiolabeled lysates of mock-transfected cells
Fig. 3. Radio-immunoprecipitation analysis of homologous interactions of the full-length viral proteins pVP2, VP3, VP4 and VP5 of IBDV in transfected
QM5 cells. QM5 cells were (co-transfected) with the indicated plasmids expressing either the full-length untagged viral proteins pVP2, VP3, VP4, and VP5
(pHB36W) or a full-length viral protein, pVP2, VP3, VP4, or VP5, fused to a c-Myc-tag (pGBKT7). At 48 h posttransfection cells were metabolically labeled
for 3 h with [35S]methionine. Subsequently, cells were lysed and immunoprecipitated with anti c-Myc serum, followed by SDS–PAGE. Positions of the viral
(fusion-) proteins and sizes of marker proteins (in kDa) are indicated.
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and of cells transfected with either the pGBKT7 or the
pGADT7 plasmid alone demonstrated that both the c-Myc
and the HA antibodies lacked cross-reactivity against the
respective fusion proteins (data not shown). When using the
c-Myc antibodies for the precipitation of c-Myc-tagged VP3,
only the HA-tagged mutant proteins VP3C129 and
VP3C161 were found to be coprecipitated (Fig. 4A, lanes
1 and 6). The same result was observed when using the HA
antibodies, where c-Myc-tagged full-length VP3 was only
coprecipitated with the HA-tagged VP3C129 and
VP3C161 proteins (Fig. 4A, lanes 8 and 13). Furthermore,
reversing the c-Myc and HA tags did not affect the observed
interactions, thus confirming the results (Fig. 4B, lanes 1, 6,
8, and 13). In addition, an interaction was observed for
mutant protein VP3N32/C129, though weak and only in
one orientation. When using the c-Myc antibodies, HA-
tagged full-length VP3 was observed to be coprecipitated
with the HA-tagged VP3N32/C129 (Fig. 4B, lane 4). For
VP5, none of the deletion mutants tested was found to be
coprecipitated with full-length VP5, either way, and irre-
spective of the orientation of the tags (data not shown).
Discussion
In the present study we confirmed and extended our
earlier analysis of the homotypic interactions of the IBDV
proteins. The use of the recently refined cleavage map of the
structural protein precursor allowed the detection of a novel
homologous interaction for VP4 by the yeast two-hybrid
system, in addition to the self-association observed earlier
for pVP2, VP3, and VP5 as well as—though weakly—for
VP1. A further characterization of the strongly interacting
pVP2, VP3, VP4, and VP5 proteins was undertaken both by
using the yeast two-hybrid system and by performing co-
immunoprecipitation analyses of coexpressed cDNA con-
structs. Through deletion mutagenesis we were able to map
the self-interacting regions in all of the proteins except for
VP4, which appeared to be very sensitive to modifications.
The data on VP3 allow us now to design a domain map in
which the different regions of the protein involved in ho-
momeric and heteromeric interactions can be assigned.
The IBDV capsid is an icosahedron with a T  13 lattice
composed of trimeric subunits (Bottcher et al., 1997; Caston
et al., 2001). The outer face of the particle is composed of
260 trimeric VP2 clusters. Closely apposed to the inside of
this protein layer are 200 Y-shaped trimeric VP3 structures.
This arrangement not only predicts the existence of homo-
meric interactions of the two capsid proteins, but their
intimate association dictates the occurrence of heteromeric
contacts as well. However, while the self-association of
both proteins came out convincingly, we failed to detect
pVP2/VP3 interactions in our assays. The reasons for this
most likely relate to the assay systems that we used. The
two-hybrid system, for instance, would be inadequate if we
assume that the interactions only occur between the trimeric
units. Also, if such heteromeric complexes would have been
formed in the coexpression system, they may not have been
sufficiently stable to survive the immunoprecipitation con-
ditions, e.g., due to the low concentration of SDS present. It
is of note that VP2/VP3 complexes were also not detected in
infected cell lysates (Tacken et al., 2000) and that the
assembly of virus-like particles from these proteins some-
how requires the VP3 protein to be “activated,” as their
formation could only be achieved after modification of its
carboxy-terminus (Chevalier et al., 2002).
We observed strong interactions between full-length
VP3 molecules in our two-hybrid assays. These interactions
were subsequently narrowed down by protein truncation to
the amino-terminal region of the molecule. Specifically, a
polypeptide comprising residues 1–97 was identified as the
domain responsible for homomeric interaction, since this
region proved to interact with its full-length cognate protein
in both the yeast two-hybrid and the coimmunoprecipitation
assay. Interestingly, this domain is clearly distinct from the
regions in the VP3 molecule known to interact with other
components in the virion. VP3 has been shown by us
(Tacken et al., 2000) as well as by others (Lombardo et al.,
1999) to bind to the viral RNA-dependent RNA polymer-
ase, VP1. We were able to map the domain in VP3 respon-
sible for this interaction to the very carboxy-terminal 10
residues (Tacken et al., 2002). In the same study we addi-
tionally demonstrated, that VP3 also interacts with both
dsRNA segments of the viral genome. The domain respon-
sible for this association has not been determined yet, but
has been implicated to occur in the carboxy-terminal region
as well, in a domain spanning residues 221–247, a highly
basic region with interspersed proline residues (Bottcher et
al., 1997; Hudson et al., 1986; Tacken et al., 2002). Impor-
tantly, deletion of the VP1-binding domain in VP3 did not
abolish VP3–dsRNA interactions (Tacken et al., 2002) nor
did it affect VP3–VP3 interaction (M.G.J. Tacken, unpub-
lished results). Conversely, deletion of the self-interacting
domain of VP3 did not affect the VP1-binding activity
(M.G.J. Tacken, unpublished results). Altogether, these data
are consistent with the independent functioning of three
domains in the VP3 protein as we depicted in the domain
model of the protein presented in Fig. 5. The drawing shows
the homomeric association function localized in the amino-
terminal one-third of the molecule, the VP1-binding seg-
ment at the opposite end of the molecule, and the dsRNA-
binding domain just preceding the latter.
Unlike VP3 (Martinez-Torrecuadrada et al., 2000b),
(p)VP2 has been shown to have a strong tendency to self-
assemble, giving rise to different types of particles depend-
ing on the conditions, varying from rigid, flexible, and
twisted tubules to smaller or larger virus-like particles (Cas-
ton et al., 2001; Chevalier et al., 2002; Fernandez-Arias et
al., 1998; Lombardo et al., 1999; Martinez-Torrecuadrada et
al., 2000a, b). Detailed electron cryomicroscopy and image
processing analyses of different types of particles clearly
revealed the trimeric VP2 structures in which each molecule
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can be subdivided into three subdomains, each capable of
interacting in a nonequivalent fashion with another VP2
molecule of the same or an adjoining trimer (Caston et al.,
2001). This constellation would predict that removal of one
such subdomain does not necessarily disable the interac-
tions by the others. Our observations support this view, as
the deletions of different domains of the pVP2 molecule
appeared not to abolish the association capacity of the
Fig. 4. Radio-immunoprecipitation analysis of truncated VP3 proteins in transfected QM5 cells. The VP3 mutant constructs (typed in bold face in Fig. 2B)
were cloned into pGBKT7 and pGADT7 expression vectors and the expressed polypeptides were tested for their ability to interact with full-length VP3. QM5
cells were cotransfected with the indicated plasmids expressing either the full-length, c-Myc-tagged VP3 protein (pGBKT7), together with a HA-tagged VP3
mutant polypeptide (pGADT7) (A), or a c-Myc-tagged VP3 mutant polypeptide together with the full-length HA-tagged VP3 protein (B). At 48 h
posttransfection cells were metabolically labeled for 3 h with [35S]methionine. Subsequently, cells were lysed and proteins were immunoprecipitated with
anti-c-Myc serum or anti-HA serum, followed by SDS–PAGE. Positions of the viral (fusion-) proteins and sizes of marker proteins (in kDa) are indicated.
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remaining polypeptides. This was also not the case after
truncation of a carboxy-terminal 128-residue segment,
which contains the 50–60 residues tail supposed to play a
crucial role in the control of the interactions between trimers
of VP2 as well as between trimers of VP2 and VP3 (Caston
et al., 2001). Without this tail domain, independently ex-
pressed VP2 assembles into T  1 capsids (Caston et al.,
2001), while this domain is essential for normal virion
morphogenesis in IBDV-infected cells (Da Costa et al.,
2002).
VP4, the viral protease, was anticipated to exhibit ho-
mologous interaction. In IBDV-infected cells this protein
assembles into distinct tubular aggregates, 24–26 nm in
diameter, known as type II tubules (Granzow et al., 1997).
Though the function of these structures in viral infection is
still unclear, they might serve to inactivate excess protease
activity, thereby preventing lethal damage to the virus or to
the cells. Attempts to identify interacting domain(s) in the
polypeptide failed; none of the deletions tested preserved
the ability of the protein to associate with its full-length
counterpart in the yeast two-hybrid assay. Negative results
in the two-hybrid assay often result from protein instability,
but that appeared not to be the case here. All described
fusion proteins were analyzed by immunoblotting and ap-
peared to accumulate in high amounts and with the expected
size (data not shown). Our observations are therefore most
compatible with the terminal domains interacting with each
other to stabilize a conformation that is required for homo-
typic association. Deletion of either terminus disrupts this
conformation and abolishes the interaction. This is also
consistent with our initial inability to detect the homotypic
interaction of VP4 in the yeast two-hybrid system (Tacken
et al., 2000). The VP4 protein that we tested in those studies
carried a 61-residue amino-terminal extension while lacking
34 residues at its carboxy-terminal, both due to the use of
incorrect precursor cleavage sites (Fig. 1C). Either or both
these defects apparently interfered with self-association.
The exact function of VP5 is still unknown. The protein
is highly basic and cysteine-rich, and its sequence is con-
served among all serotype I IBDV strains (95% identity).
A VP5-deficient virus can replicate in the bursa of inocu-
lated chickens but does not induce bursal lesions (Yao et al.,
1998). It has also been demonstrated that this VP5-deficient
mutant IBDV remains closely associated with and is not
efficiently released from infected cells (Yao and Vakharia,
2001). The protein has therefore been speculated to some-
how facilitate progeny virus release (Yao and Vakharia,
2001). Recently, it was shown that VP5 accumulates within
the host cell plasma membrane (Lombardo et al., 2000).
Expression of VP5 resulted in alteration of cell morphology,
disruption of the plasma membrane, and a drastic reduction
of cell viability (Lombardo et al., 2000). Furthermore, the
protein is capable of inducing a programmed cell death
response in culture cells (Yao and Vakharia, 2001). Se-
quence-based topology predictions indicated that VP5 is a
class II membrane protein, having an intracellular amino-
terminal tail, a transmembrane helix, and an extracellular
carboxy-terminal region (Lombardo et al., 2000). Interest-
ingly, the putative self-interacting domain of VP5 that we
mapped in our two-hybrid analysis to the domain compris-
ing residues 73–90 corresponds almost exactly to the pre-
dicted transmembrane region (residues 69–88) of the pro-
tein. Due to the common -helical structure of
transmembrane domains, many are considered to form
channels or pores in the membrane by a so-called “barrel-
stave” mechanism (reviewed in Ojcius and Young, 1991).
The observation that the plasma membrane of VP5-express-
ing cells was permeable not only to small molecules, but
also to macromolecules such as lectin and IgG molecules
(Lombardo et al., 2000), strongly supports the hypothesis
that VP5 molecules indeed form pore structures within the
plasma membrane. In addition, these observed changes in
membrane permeability are similar to those produced in
Escherichia coli by the viral proteins E1 of hepatitis C virus,
Fig. 5. A domain model for VP3. Functional binding domains are indicated as shaded boxes. The binding site for VP1 has been mapped previously to the
extreme carboxy-terminus (Tacken et al., 2002), while the approximate one-third amino-terminal region was presently shown to be responsible for homomeric
interaction. The site for dsRNA interaction has not been precisely defined yet, though it has been postulated to comprise the indicated stretch of amino acids
(Caston et al., 2001; Hudson et al., 1986; Tacken et al., 2002). The graded line above the upper bar representing the VP3 polypeptide indicates the amino
acid (AA) residue numbers.
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M2 of influenza virus, gp41 of human immunodeficiency
virus, and 3AB of poliovirus, whose transmembrane do-
mains are also thought to cause pore formation (Arroyo et
al., 1995; Ciccaglione et al., 2001; Guinea and Carrasco,
1994; Lama and Carrasco, 1992, 1995). The barrel-stave
mechanism involves three major steps: (i) binding of mono-
mers to the membrane; (ii) insertion into the membrane to
form a pore; and (iii) progressive recruitment of additional
monomers to increase the pore size (Shai, 1995). Initial
assembly of monomers on the surface of the membrane
must occur before the peptide is inserted, since it is ener-
getically unfavorable for an amphipatic -helix to traverse
the membrane as a monomer. A homotypic interaction of
VP5 through a self-interacting domain located within its
predicted membrane-spanning region is therefore consistent
with the hypothesis that VP5 molecules coassemble at the
host plasma membrane to form a pore structure. It would
hence be interesting to evaluate whether mutations of con-
served amino acids in the putative transmembrane region of
VP5 would affect its membrane-permeabilizing activity.
Shortcomings of the individual methods used in this
study necessitate a cautious interpretation of data observed
just by one type of assay. This is for instance obvious from
those cases where we were unable to confirm protein inter-
actions by the coimmunoprecipitation assay that had been
convincingly demonstrated in the yeast system, as exempli-
fied by some of the VP3 and all VP5 truncation constructs
that were tested by both approaches. Such inconsistencies
between the two techniques are frequently observed (Vidal
and Legrain, 1999; Warbrick, 1997). Our yeast two-hybrid
deletion analysis of amino- and carboxy-terminally trun-
cated VP3 molecules showed that neither the first 32 nor the
last 129 amino acids of VP3 were necessary for VP3–VP3
interaction. However, the strongly interacting deletion mu-
tant VP3N32/C129, which lacks both these terminal do-
mains, was found not to be efficiently coimmunoprecipi-
tated when coexpressed with full-length VP3. On the other
hand, the VP3 deletion mutant VP3C161, which differs
from mutant VP3N32/C129 only by having its amino-
terminus intact, clearly interacted with full-length VP3 in
both the two-hybrid and the coimmunoprecipitation assays.
Because the two-hybrid LexABD and B42AD fusion proteins
were stably expressed and negative for self-activation of the
LEU2 and LacZ reporter genes, we attach much value to the
positive results obtained with the yeast two-hybrid system.
Thus, the deletion mutant VP3N32/C129 most likely be-
haved as a bona fide VP3 partner in the yeast two-hybrid
system. In contrast, there are many possible causes for
negative results in the immunoprecipitation assay. One is
the effect of the c-Myc or HA tags used in this assay. These
extensions might sterically hinder interaction of the fusion
proteins or reduce their interaction strength. Alternatively,
their interaction might become destabilized by the binding
of antibodies to the tags. While these considerations leave
us with uncertainties about some of our—unconfirmed—
observations and at the same time ask for additional, inde-
pendent interaction assays, the combined results of our
study provide a good basis for the further analysis of these
important interactions in the future.
Material and methods
Cell line, virus, plasmid, and bacterial and yeast strains
QM5 cells (Antin and Ordahl, 1991) were cultured in
QT35 medium (Gibco-BRL) supplemented with 5% fetal
calf serum (FCS) and 2% antibiotic solution ABII [1000 U
of penicillin (Yamanouchi), 1 mg of streptomycin (Radi-
umfarma), 20 g amphotericin B (Fungizone), 500 g poly-
mixin B, and 10 mg kanamycin/ml] in a CO2 (5%) incubator
at 37°C. Recombinant fowlpox virus expressing the T7
polymerase gene (FPV-T7) (Britton et al., 1996) was re-
ceived from the laboratory of M. Skinner (Compton Labo-
ratory, Berks, UK). The preparation of the plasmid
pHB36W, which contains the full-length genomic cDNA of
segment A of IBDV strain CEF94, has been described (Boot
et al., 1999). E. coli strain DH5- (Life Technologies) was
used during DNA manipulations. Yeast strain S. cerevisiae
EGY48 (MAT, his3, trp1, ura3, LexAop(x6)-LEU2) was
used for the yeast two-hybrid analyses. Yeast strain S.
cerevisiae EGY48[p8oplacZ] is the host strain EGY48
transformed with the autonomously replicating reporter
plasmid p8op-LacZ (Clontech).
Construction of two-hybrid expression plasmids
The plasmids pLexABD-VP1, pLexABD-VP5, pB42AD-
VP1, pB42AD-VP5, containing the cDNA sequence encod-
ing VP1 or VP5 of IBDV strain CEF94, have been de-
scribed previously (Tacken et al., 2000). Copy DNA
encoding the full-length sequences of pVP2, VP3, and VP4
of IBDV strain CEF94, as well as defined parts of VP5,
pVP2, VP3, and VP4 (see Fig. 2), were amplified by PCR
by using the Expand high-fidelity PCR system (Boehringer
Mannheim). Plasmid pHB36W was used as a template. The
sets of primers used were designed to introduce an EcoRI
site at the upstream (5) end and a stop codon plus either a
SalI site or a XhoI site at the downstream (3) end of each
coding sequence (Table 1). The PCR products were precip-
itated, digested with EcoRI/SalI or EcoRI/XhoI, gel purified
by the QIAEX-II method (QIAGEN), and ligated with T4
ligase (New England BioLabs) into the yeast expression
vectors pLexABD and pB42AD (Clontech). These vectors
had previously been digested with EcoRI/XhoI. The ligation
mix was transformed into E. coli DH5- cells, which were
subsequently grown under ampicillin selection. Plasmid
DNA prepared from several independent transformants was
screened for the presence of the insert, and plasmids from
positive clones were sequenced at the fusion junction by
cycle sequencing using an ABI 310 sequencer (PE Applied
Biosystems) to ensure correct reading frames. Control plas-
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mids pLexABD-53 (human p53 gene in pLexABD), pB42AD-
SV40 T (SV40 large T antigen in pB42AD), and pLexABD-
Lamin C (human Lamin C gene in pLexABD) were from
Clontech.
Two-hybrid analysis
All two-hybrid media, buffers, and protocols were as
described in the Clontech Manual for the Matchmaker LexA
Two-Hybrid System and in the Clontech Yeast Protocols
Handbook (Clontech). The yeast strain S. cerevisiae
EGY48[p8op-lacZ], which contains two reporter genes,
LEU2 and LacZ, under the control of two independent
promoters, was transformed by using the lithium acetate
method with pLexABD (HIS3) and pB42AD (TRP1) con-
structs carrying VP1, pVP2, VP3, VP4, and VP5, in every
possible pairwise combination. Control plasmids were
pLexABD-Lamin C (Clontech), pLexABD-53 (Clontech),
pB42AD-SV40 T (Clontech), and pB42AD-empty vector.
This resulted in 37 pairwise transformations (see Tables 2
and 3) that were plated onto SD/Glu/-His/-Ura/-Trp me-
dium. About 10 His Ura Trp colonies from each trans-
formation were subsequently plated onto SD/Gal/Raf/-His/
-Ura/-Trp/-Leu medium to assess the transcriptional activa-
tion of the LEU2 reporter gene and onto SD/Gal/Raf/5-
bromo-4-chloro-3-indolyl--D-galactopyranoside (X-gal)/-His/
-Ura/-Trp medium to assess the transcriptional activation of the
LacZ reporter gene.
Stable expression of the hybrid proteins was verified
by Western blot analysis according the manufacturer’s
instructions (Clontech). The ability of the LexA fusions
used in this study to bind operator DNA was confirmed
by a repression assay. For this, yeast strain S. cerevisiae
EGY48 was transformed with the URA3 plasmid
pJK101 (OriGene) and, in parallel, with pJK101 together
with one of the pLexABD constructs carrying VP1, pVP2,
VP3, VP4, or VP5. Transformed yeast cells were plated
onto SD/Glu/-Ura or SD/Glu/-His/-Ura medium, respec-
tively. Plasmid pJK101 contains a LacZ reporter gene
whose expression is driven by the yeast GAL1 promoter.
However, two LexA operators have been placed between
the GAL1 promoter and the lacZ gene. When a LexABD
fusion protein binds to these operators, there will be a
decrease in the level of GAL1-driven lacZ expression. A
liquid assay to quantify -galactosidase activities was
performed by growing transformants to mid log phase in
the appropriate selection medium, SD/Gal/Raf/-Ura or
SD/Gal/Raf/-His/-Ura, and using O-nitrophenyl--D-
galactoside as the chromogenic substrate. Each enzyme
activity assay was performed with at least five indepen-
Table 1
Sequences of primers used for the construction of the yeast two-hybrid expression plasmids
Primer Nucleotide sequencea Orientation Polypeptide
p001 ccgGAATTCATGACAAACCTGCAAGATCAAACCC  pVP2, pVP2C128, and pVP2C256
p122 ccgGAATTCTTCCAAGGAAGCCTGAGTGAACTG  pVP2N128 and pVP2N128/C128
p120 ccgGAATTCCTGGGCGCCACCATCTACCTC  pVP2N256
p054 aagtGTCGACTCAGGCGAGAGTTAGCTGCCTTATGC  pVP2, pVP2N128, and pVP2N256
p157 taaCTCGAGTCAAACCAGGTTCTTTGCTAGTTCAGG  pVP2C128 and pVP2N128/C128
p119 taaCTCGAGTCATACAAGGCCGTGGACGCTTGTTTG  pVP2C256
p057 tcGAATTCGCTTCAGAGTTCAAAGAGACCCCC  VP3, VP3C64, VP3C129, and VP3C161
p131 ccgGAATTCGTGTTCATGTGGCTGGAAGAGAATG  VP3N32/C64, VP3N32/C129, and VP3N32/C161
p062 ccgGAATTCAACGCACCACAAGCAGGCAGCAAG  VP3N64 and VP3N64/C64
p060 ccgGAATTCGGCCAGCTAAAGTACTGGCAGAAC  VP3N129
p006 gatcGTCGACTCACTCAAGGTCCTCATCAGAGAC  VP3, VP3N64 and VP3N129
p063 aagtGTCGACTCAATAGACTTTGGCAACTTCGTCTATG  VP3C64, VP3N64/C64, and VP3N32/C64
p061 aagtGTCGACTCAGCTTGGCCCTCGGTGCCCATTG  VP3C129 and VP3N32/C129
p132 aagtGTCGACTCACCTCTGTGCTTCCTCTGGTGTGG  VP3N32/C161 and VP3C161
p055 agGAATTCGCCGACAAGGGGTACGAGGTAGTC  VP4, VP4C61, and VP4C122
p144 ccgGAATTCAAAGCATTGAACAGCAAAATG  VP4N60 and VP4N60/C61
p124 ccgGAATTCTGGGACGACAGCATTATGCTGTCC  VP4N121
p143 taaCTCGAGTCAGGCCATGGCCAGGTCGTAC  VP4, VP4N60, and VP4N121
p125 taaCTCGAGTCAGGCGAGCTTGGTGCTTCTAAAGC  VP4C61 and VP4N60/C61
p123 taaCTCGAGTCAGACATCATCTATTGGGACAACGGTG  VP1C122
p007 ccgGAATTCATGGTCAGTAGAGATCAGACAAACG  VP5C37, VP5C73, and VP5C55
p130 ccgGAATTCGGCGTCCATTCCGGACGACACC  VP5N36, VP5N36/C37, and VP5N36/C55
p128 ccgGAATTCTGGATTCCCTGGCTCAATTGTGGG  VP5N72 and VP5N72/C37
p145 ccgGAATTCCTACAAGTTCGATCAGATGCTCCTG  VP5N90
p008 gatcGTCGACTCACTCAGGCTTCCTTGGAAGGTC  VP5N36, VP5N72, and VP5N90
p129 taaCTCGAGTCATTGTAACTGGCCGGTAGGTTCTG  VP5C37, VP5N36/C37, and VP5N72/C37
p146 ttgCTCGAGTCATTCCCATTGCTCTGCAGTGTGTAG  VP5C55 and VP5N36/C55
p127 taaCTCGAGTCAGGGAAAAAGACAATTAGCCCTGAC  VP5C73
a The primer sequences are listed 5 to 3. Restriction sites are in italics. Nucleotides 5 of a restriction site which are unable to hybridize with the IBDV
cDNA are in lower case. Bold letters indicate an in-frame stop codon.
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dent colonies and -galactosidase-specific activities were
calculated as described by Clontech.
Construction of the expression plasmids for
coimmunoprecipitation analysis
The c-Myc-tag and HA-tag fusions were cloned as fol-
lows. The pVP2, VP3, VP4, VP5 (or defined parts thereof)
containing inserts were excised from their respective
pLexABD-vectors described above, through restiction en-
zyme digestion with either EcoRI/XhoI or EcoRI/SalI.
These fragments were gel purified by the QIAEX-II method
(QIAGEN) and ligated with T4 ligase (New England Bio-
Labs) into the vectors pGBKT7 and pGADT7 (Clontech).
The vector pGBKT7 had previously been digested with
EcoRI/SalI and the vector pGADT7 had previously been
digested with EcoRI/XhoI. The ligation mix was trans-
formed into E. coli DH5- cells, which were subsequently
grown either under kanamycin (pGBKT7) or ampicillin
(pGADT7) selection. Plasmid DNA prepared from several
independent transformants was screened for the presence of
the insert, and plasmids from positive clones were se-
quenced at the fusion junction by cycle sequencing using an
ABI 310 sequencer (PE Applied Biosystems) to ensure
correct reading frames.
Transfection of QM5 cells
QM5 cells were grown to 80% confluency in 60-mm
dishes and infected with FPV-T7 [multiplicity of infection
(M.O.I.  3)]. After 1 h, the cells were washed once with 5
ml QT35 medium and covered with 5 ml of Optimem 1
(Gibco-BRL). In the meantime, 2.0 g of DNA was mixed
with 25 l Lipofectamine (Gibco-BRL) in 0.5 ml Optimem
1 and kept at room temperature for at least 30 min. The
QM5 cells were subsequently covered with 4 ml of fresh
Optimem 1, and the DNA-Lipofectamine mixture was
added. The transfection was performed overnight (18 h) in
a 37°C incubator (5.0% CO2). The transfected monolayer
was rinsed once with QT35 medium and fresh QT35 me-
dium supplemented with 5% FCS and 2% ABII was added,
and the plates were incubated for another 24 h.
Radiolabeling of transfected cells and
immunoprecipitation
At 48 h posttransfection, cells were starved for 1 h in
methionine-free EMEM medium (Gibco-BRL). Cells were
then labeled for 3 h with 20 Ci/ml of [35S]methionine
(Amersham) in methionine-free EMEM medium. At the end
of the labeling, the cell cultures were lysed on ice in 1 
Table 2
Interactions between the viral proteins of IBDV strain CEF94 in the yeast two-hybrid system, assayed for leucine autotrophy
B42AD fusion LexABD fusion
VP1 pVP2 VP3 VP4 VP5 Lamin C 53
VP1 /      nd
pVP2       nd
VP3       nd
VP4       nd
VP5       nd
No insert       nd
SV40 T nd nd nd nd nd nd 
Note. Growth was recorded after 1 day when the strain with LexABD-p53 and B42AD-SV40 T antigen (positive control) showed clear growth. , clear
growth after 1 day (very strong interaction); /, limited growth (weak interaction); , no growth (no interaction); nd, not determined. All results shown
are representative of at least seven independent transformants.
Table 3
Interactions between the viral proteins of IBDV strain CEF94 in the yeast two-hybrid system, assayed for -galactosidase activity
B42AD fusion LexABD fusion
VP1 pVP2 VP3 VP4 VP5 Lamin C 53
VP1       nd
pVP2       nd
VP3       nd
VP4       nd
VP5       nd
No insert       nd
SV40 T nd nd nd nd nd nd 
Note. The relative strength of the interaction was judged by intensity of the blue phenotype after 1 day when the strain with LexABD-p53 and B42AD-SV40
T antigen (positive control) had deep blue colonies., deep blue colonies (very strong interaction);, light blue colonies (interaction);, white colonies
(no interaction); nd, not determined. All results shown are representative of at least seven independent transformants.
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PBS-TDS lysis buffer, using a 5  PBS-TDS lysis buffer
stock solution (5% Triton X-100, 2.5% sodium deoxy-
cholate, 0.5% SDS, 0.7 M NaCl, 14 mM KCl, 50 mM
Na2HPO4, 7.5 mM KH2PO4). Cell debris was removed by
centrifugation at 4°C for 20 min at 13,000 g. All lysates
were pretreated with Protein A Sepharose (Amersham) be-
fore they were used for immunoprecipitation with either
monoclonal anti-c-Myc serum (Clontech) or polyclonal
anti-HA serum (Clontech). Protein A Sepharose bound im-
mune complexes were washed three times in 1 PBS-TDS
lysis buffer and eluted in 30 l sodium dodecyl sulfate
(SDS) sample buffer [60 mM Tris–HCl (pH 6.8), 2.5%
SDS, 5% -mercaptoethanol, 10% glycerol, 0.1% bromphe-
nol blue]. Proteins were resolved in 18% separating gels by
SDS–polyacrylamide gel electrophoresis (SDS–PAGE) and
visualized by autoradiography.
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